Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance | Zendy

André Furco | Zendy; Bhairvi Gosrani | Zendy; Sara Nicholas | Zendy; Amanda Williams | Zendy; Wunmi Braithwaite | Zendy; Anton Pozniak | Zendy; Graham P. Taylor | Zendy; David Asboe | Zendy; Hermione Lyall | Zendy; Andrew J Shaw | Zendy; Moses Kapembwa | Zendy

Open Access

Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance

Author(s) -

André Furco,

Bhairvi Gosrani,

Sara Nicholas,

Amanda Williams,

Wunmi Braithwaite,

Anton Pozniak,

Graham P. Taylor,

David Asboe,

Hermione Lyall,

Andrew J Shaw,

Moses Kapembwa

Publication year - 2009

Publication title -

aids

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.195

H-Index - 216

eISSN - 1473-5571

pISSN - 0269-9370

DOI - 10.1097/qad.0b013e32832027d6

Subject(s) - emtricitabine , darunavir , nevirapine , etravirine , efavirenz , lamivudine , virology , didanosine , enfuvirtide , medicine , ritonavir , atazanavir , zidovudine , lopinavir , nelfinavir , resistance mutation , reverse transcriptase inhibitor , pharmacology , viral load , reverse transcriptase , biology , immunology , virus , viral disease , gp41 , hepatitis b virus , polymerase chain reaction , antiretroviral therapy , antigen , epitope , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research